Literature DB >> 35100504

Aulosirazoles B and C from the Cyanobacterium Nostoc sp. UIC 10771: Analogues of an Isothiazolonaphthoquinone Scaffold that Activate Nuclear Transcription Factor FOXO3a in Ovarian Cancer Cells.

Lydia J Davis1, Amanda C Maldonado1, Manead Khin1, Aleksej Krunic1, Joanna E Burdette1, Jimmy Orjala1.   

Abstract

The known solid-tumor-selective cytotoxin aulosirazole (1) was identified from bioactive extracts from the culture medium of the cyanobacterium Nostoc sp. UIC 10771. Here, we demonstrate that 1 induces the nuclear accumulation of FOXO3a in OVCAR3 using both Western blot analysis and immunofluorescence confocal microscopy. We also report the discovery of two additional analogues, aulosirazoles B (2) and C (3). Structures for compounds 2 and 3 were determined using HR-ESI-LC-MS/MS and 1D and 2D NMR experiments. Aulosirazoles B (2) and C (3) represent the first natural analogues of the FOXO-activating compound aulosirazole (1) and are the second and third isothiazole-containing metabolites reported from this phylum.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35100504      PMCID: PMC8957594          DOI: 10.1021/acs.jnatprod.1c01030

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  27 in total

Review 1.  The unique mechanistic transformations involved in the biosynthesis of modular natural products from marine cyanobacteria.

Authors:  Adam C Jones; Emily A Monroe; Eli B Eisman; Lena Gerwick; David H Sherman; William H Gerwick
Journal:  Nat Prod Rep       Date:  2010-05-04       Impact factor: 13.423

Review 2.  FOXO transcription factors at the interface of metabolism and cancer.

Authors:  Wolfgang Link; Pablo J Fernandez-Marcos
Journal:  Int J Cancer       Date:  2017-07-10       Impact factor: 7.396

3.  Improving the coverage of the cyanobacterial phylum using diversity-driven genome sequencing.

Authors:  Patrick M Shih; Dongying Wu; Amel Latifi; Seth D Axen; David P Fewer; Emmanuel Talla; Alexandra Calteau; Fei Cai; Nicole Tandeau de Marsac; Rosmarie Rippka; Michael Herdman; Kaarina Sivonen; Therese Coursin; Thierry Laurent; Lynne Goodwin; Matt Nolan; Karen W Davenport; Cliff S Han; Edward M Rubin; Jonathan A Eisen; Tanja Woyke; Muriel Gugger; Cheryl A Kerfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-31       Impact factor: 11.205

4.  Unlocking the Spatial Control of Secondary Metabolism Uncovers Hidden Natural Product Diversity in Nostoc punctiforme.

Authors:  Daniel Dehm; Julia Krumbholz; Martin Baunach; Vincent Wiebach; Katrin Hinrichs; Arthur Guljamow; Takeshi Tabuchi; Holger Jenke-Kodama; Roderich D Süssmuth; Elke Dittmann
Journal:  ACS Chem Biol       Date:  2019-05-24       Impact factor: 5.100

5.  (+)-Anatoxin-a is a potent agonist at neuronal nicotinic acetylcholine receptors.

Authors:  P Thomas; M Stephens; G Wilkie; M Amar; G G Lunt; P Whiting; T Gallagher; E Pereira; M Alkondon; E X Albuquerque
Journal:  J Neurochem       Date:  1993-06       Impact factor: 5.372

6.  DNA fingerprinting of the NCI-60 cell line panel.

Authors:  Philip L Lorenzi; William C Reinhold; Sudhir Varma; Amy A Hutchinson; Yves Pommier; Stephen J Chanock; John N Weinstein
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

Review 7.  Therapeutic strategies targeting FOXO transcription factors.

Authors:  Giampaolo Calissi; Eric W-F Lam; Wolfgang Link
Journal:  Nat Rev Drug Discov       Date:  2020-11-10       Impact factor: 84.694

8.  Verticillin A Causes Apoptosis and Reduces Tumor Burden in High-Grade Serous Ovarian Cancer by Inducing DNA Damage.

Authors:  Amrita Salvi; Chiraz Soumia M Amrine; Julia R Austin; KiAundra Kilpatrick; Angela Russo; Daniel Lantvit; Esther Calderon-Gierszal; Zachary Mattes; Cedric J Pearce; Mark W Grinstaff; Aaron H Colby; Nicholas H Oberlies; Joanna E Burdette
Journal:  Mol Cancer Ther       Date:  2020-01       Impact factor: 6.261

Review 9.  High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints.

Authors:  Michael-Antony Lisio; Lili Fu; Alicia Goyeneche; Zu-Hua Gao; Carlos Telleria
Journal:  Int J Mol Sci       Date:  2019-02-22       Impact factor: 5.923

Review 10.  FOXO transcription factor family in cancer and metastasis.

Authors:  Yannasittha Jiramongkol; Eric W-F Lam
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.